Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on: April 03,2026

Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on:April 03,2026

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer

Updated on: April 03,2026

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer

Updated on:April 03,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on: March 28,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on:March 28,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on: April 02,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on:April 02,2026

Transforming cancer treatment with ultrasound

by Dan Bernardi,Syracuse UniversityCredit:Chemical Science(2025). DOI: 10.1039/d5sc05710hChemotherapy has long been a cornerstone of cancer treatment, but its effectiveness comes at a cost. The powerf

Updated on: April 05,2026

Transforming cancer treatment with ultrasound

by Dan Bernardi,Syracuse UniversityCredit:Chemical Science(2025). DOI: 10.1039/d5sc05710hChemotherapy has long been a cornerstone of cancer treatment, but its effectiveness comes at a cost. The powerf

Updated on:April 05,2026

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based

Updated on: April 07,2026

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based

Updated on:April 07,2026

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on: April 07,2026

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on:April 07,2026

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on: April 09,2026

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on:April 09,2026

DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on: April 16,2026

DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on:April 16,2026